ProBioGen and Nouscom Sign License Agreement for ProBioGen’s Technology Platform
Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate
Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate
This year, Bayer G4A programs are embarking on one mission: to put people at the center of their health.
The 2018 Dealmaker program aims to connect mature startups and companies with a market-ready product or a solution in healthcare to tackle…
Joint press release by Berlin Institute of Health and Charité – Universtätsmedizin Berlin
Avoidable errors in preclinical research often result in patients being subjected to studies where the risks are high and the chances of success are low.…
Eckert & Ziegler AG, a specialist for scientific, medical, and industrial applications of radioisotopes, has been selected as manufacturing partner for clinical supply of Bayer's innovative Targeted Thorium Conjugates (TTCs) in Europe. TTCs are a…
Researchers from Charité – Universitätsmedizin Berlin and Justus-Liebig-Universität (JLU) Gießen have identified a new hepatitis B virus in Brazilian capuchin monkeys. Their research, which offers insights into the evolution of hepatitis B viruses in…
Ultrasound technology may replace the need for liver biopsies
The most commonly used approach for identifying areas of hypoperfusion on perfusion magnetic resonance images is visualization and manual delineation by the clinician. This approach is both subjective and time-consuming, thus unsuitable…
Challenge
Loss of bone health is a global health problem in aging populations. Every third women and every fifth men is at risk of osteoporosis. Osteoporosis results from misbalance of bone resorption and formation processes. These misbalances…
In case of a tooth loss, there are several techniques available for the artificial replacing of the tooth. However, most of these tooth replacement techniques require a severe surgical intervention. Moreover, most of these artificial implants do…
MagForce AG (Frankfurt, Scale, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that it has entered into a collaboration agreement with Independent Public Clinical…